Prats-Puig et al. [43] concluded that SFRP5 may be an anti-inflammatory adipokine that could be negatively regulated during obesity development, leading to a less-favorable metabolic phenotype. This evidence concerns the gene SFRP5 and obesity due to melanocortin 4 receptor deficiency.